A group of stakeholders including medical device makers have penned a letter to Centers for Medicare & Medicaid Services administrator Mehmet Oz to urge the agency to cover breakthrough medical ...

In Ionis Pharmaceuticals Inc.’s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as a prophylactic therapy in the rare and genetic disease hereditary angioedema ...

Deficiencies in interferon-stimulated gene 15 (ISG15), a protein that normally regulates the immune response, causes mild but persistent inflammation. However, its absence also provides an unexpected ...

The Medicare Payment Advisory Commission said in a recent report that Medicare spending in the U.S. is poised to nearly double to $1.9 trillion over the coming eight years, a figure that is likely to ...

A new method for accelerating the maturation of neuronal cell models and brain organoids is poised to make it possible to track the etiology of neurodegenerative diseases that develop over decades.

No matter what level of tariff the Trump administration ends up imposing on biopharmaceuticals across the world, drugs and ...

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s ...

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the formation of an invasive and proliferative ...

An investigation of the epidemiology and clinical characteristics of neuropathic pain in the UK Biobank has led to the ...

Calcific aortic valve disease (CAVD) is the most prevalent acquired valve heart disorder in aging populations. Its most ...

Despite the success of traditional viral-based CAR T-cell therapies against several blood malignancies, their efficacy ...

Novocure GmbH said it submitted a premarket approval application to the U.S. FDA for its Optune Lua wearable device tumor treating fields therapy for the treatment of locally advanced pancreatic ...